Jianyang Weng
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Liver physiology and pathology, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Digestive system and related health
Most-Cited Works
- → Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal–Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer(2014)133 cited
- → Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ–PI3Kδ Dual Inhibitors(2019)35 cited